Surprisingly Useful AI Article Enhancements
Hong Kong-based surgical robotics company Cornerstone Robotics will present at the 2nd Global Health Summit (GHS 2026), with Founder and CEO Professor Samuel Au set to deliver a keynote address on the future of robotic surgery.
The summit will take place on August 7-8, 2026 at the Hong Kong Convention and Exhibition Centre, bringing together more than 1,000 healthcare innovators, investors and policymakers from around the world.
Professor Au’s keynote is titled “The Future of Surgery: Accessibility, Connectivity, and Physical AI in Robotic Surgery” and is scheduled for August 7 between 12:45 and 15:05 HKT. The presentation will examine how technology accessibility, system connectivity and digital integration are shaping the next phase of surgical robotics.
A central theme of the address will be the potential for surgical robots to evolve beyond precision tools into collaborative partners in the operating theatre, driven by advances in perception, learning capabilities and AI.
Sentire system gains international approvals
Cornerstone Robotics plans to use its flagship Sentire Endoscopic Surgical System as a case study during the keynote.
The system has received marketing approval from China’s National Medical Products Administration (NMPA). During the first half of 2026, it also obtained certification under the European Union Medical Device Regulation (CE MDR) and clearance from the Health Sciences Authority (HSA) of Singapore.
The Sentire system has since been deployed in clinical practice at hospitals across Asia-Pacific and Europe. The company points to those regulatory approvals as evidence that its product capabilities have gained recognition in multiple international markets.
Professor Au’s presentation will examine how improvements in accessibility, connectivity and digital technology integration can extend access to medical resources for a broader community of patients and healthcare professionals.
Au outlines vision for surgical robotics
“With the rapid advancement of robotics, digital health and artificial intelligence, the future of surgical robotics is entering a new phase – one that goes beyond greater precision to embrace greater accessibility, seamless connectivity and increasingly intelligent systems with advanced perception and learning capabilities,” Professor Au explained.
“These capabilities will transform robots from instruments of execution into intelligent collaborative partners, driving a fundamental shift in how surgery is performed.”
He added that Cornerstone Robotics remains committed to “innovation-driven development and deepening our global presence.”
“We look forward to working alongside innovators, clinicians and investors worldwide to shape the future of intelligent surgery, bringing accessible surgical robotic solutions to patients in need around the world,” he continued.
About the summit
GHS 2026 is jointly organised by the Hong Kong Investment Corporation Limited (HKIC) and New Frontier under the theme “Exponential Leap – From Breakthrough Discovery to Global Impact.”
The summit serves as a platform for exchange and collaboration in life sciences innovation across the Asia-Pacific region. More information is available at https://www.ghs2026.org.
Cornerstone Robotics
Cornerstone Robotics was established and incubated in Hong Kong. The company operates three global R&D hubs and six business centres worldwide and has built a 30,000-square-metre manufacturing facility in China.
Related: Best Business Laptops for work & school
Related: Best Gaming Laptops
Related: Best Portable Laptop
The Sentire surgical system was developed entirely in-house and has completed multi-specialty clinical trials. It has received market approval in multiple countries and regions, including China, the European Union and Singapore.
More information is available at https://en.csrbtx.com/.
Summit organisers
HKIC was established in 2022 as a patient capital institution wholly owned by the Hong Kong SAR Government. It adopts an “Investment +” approach, seeking reasonable financial return in the medium to long term while supporting growth in Hong Kong’s economy.
The organisation currently manages the Hong Kong Growth Portfolio, Greater Bay Area Fund, Strategic Tech Fund and Co-Investment Fund. It focuses on three sectors: hard and core technology; biotechnology and health technology; and new energy and green technology.
To date, HKIC has invested in over 200 projects. Every Hong Kong dollar invested by HKIC has attracted more than eight Hong Kong dollars from long-term capital. More information is available at https://www.hkic.org.hk.
New Frontier Group was founded in 2016 and is headquartered in Hong Kong. It is an integrated healthcare and life sciences group built on a patient-centred philosophy, spanning six business segments: integrated clinical healthcare (including United Family Healthcare, HEAL Medical and the Hong Kong Integrated Oncology Centre); rehabilitation healthcare; home healthcare; health insurance; life sciences; and medical artificial intelligence.
The group’s service network extends to approximately 80 cities across mainland China, serving close to 10 million outpatient visits and nearly 1.5 million inpatients each year. New Frontier Group employs approximately 11,000 staff across mainland China.
Last Updated on July 19, 2026 by Nick Ross
